Biomolecular NMR Assignments

, Volume 12, Issue 1, pp 37–42 | Cite as

Backbone resonance assignment of the human uracil DNA glycosylase-2

  • Hesna Kara
  • Luc Ponchon
  • Serge Bouaziz


The HIV-1 viral protein R (Vpr) is incorporated into virus particle during budding suggesting that its presence in the mature virion is required in the early steps of the virus life cycle in newly infected cells. Vpr is released into the host cell cytoplasm to participate to the translocation of the preintegration complex (PIC) into the nucleus for integration of the viral DNA into the host genome. Actually, Vpr plays a key role in the activation of the transcription of the HIV-1 long terminal repeat (LTR), mediates cell cycle arrest in G2 to M transition, facilitates apoptosis and controls the fidelity of reverse transcription. Moreover, Vpr drives the repair enzyme uracil DNA glycosylase (UNG2) towards degradation. UNG2 has a major role in “Base excision repair” (BER) whose main function is to maintain genome integrity by controlling DNA uracilation. The interaction of Vpr with the cellular protein UNG2 is a key event in various stages of retroviral replication and its role remains to be defined. We have performed the structural study of UNG2 by NMR and we report its (1HN, 15N, 13Cα, 13Cβ and 13C′) chemical shift backbone assignment and its secondary structure in solution as predicted by TALOS-N. We aim to determine with accuracy by NMR, the residues of UNG2 interacting with Vpr, characterize their interaction and use the local structure of UNG2 and its interface with Vpr to propose potential ligands disturbing this interaction.


HIV-1 UNG2 Vpr Base excision repair 



We would like to thank the TGIR-RMN program for the financial support. Thanks a lot to Dr. François-Xavier Canterelle at Lille University and to Dr. Nelly Morellet at ISCN institute at Gif-sur-Yvette for their help during the recording of the experiments and for their technical advices. We also thank Dr. Nathalie Chazal at UMR 9004 CNRS-Université Montpellier, for the UNG2 (93-313) Plasmid construction.


  1. Ahn J, Vu T, Novince Z, Guerrero-Santoro J, Rapic-Otrin V, Gronenborn AM (2010) HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-RING E3 ubiquitin ligase for proteasome-dependent degradation. J Biol Chem 285(48):37333–37341CrossRefGoogle Scholar
  2. Bax A, Ikura M (1991) An efficient 3D NMR technique for correlating the proton and15N backbone amide resonances with the α-carbon of the preceding residue in uniformly15N/13C enriched proteins. J Biomol NMR 1(1):99–104CrossRefGoogle Scholar
  3. Chauhan A, Tikoo A, Patel J, Abdullah AM (2014) HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest. Neurosci Res 88:16–22CrossRefGoogle Scholar
  4. de Goede AL, Vulto AG, Osteraus AD, Gruters RA (2015) Understanding HIV infection for the design of a therapeutic vaccine. Part I : epidemiology and pathogenesis of HIV infection. Ann Pharm Fr 73(2):87–99CrossRefGoogle Scholar
  5. Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Lelievre JD, Benkirane M (2017) CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature 543(7646):564–567ADSCrossRefGoogle Scholar
  6. Fenard D, Houzet L, Bernard E, Tupin A, Brun S, Mougel M, Devaux C, Chazal N, Briant L (2009) Uracil DNA glycosylase 2 negatively regulates HIV-1 L transcription. Nucleic Acids Res 37:6008–6018CrossRefGoogle Scholar
  7. Fritz JV, Briant L, Mély Y, Bouaziz S, de Rocquigny H (2010) HIV-1 viral protein R: from structure to function. Future Virol 5:607–625CrossRefGoogle Scholar
  8. Hagen L, Kavli B, Sousa MM, Torseth K, Liabakk NB, Sundheim O, Penă-Diaz J, Otterlei M, Hørning O, Jensen ON, Krokan HE, Slupphaug G (2008) Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA. EMBO J 27:51–61CrossRefGoogle Scholar
  9. Grzesiek S, Bax A (1993) Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J Biomol NMR 3(2):185–204CrossRefGoogle Scholar
  10. Kavli B, Sundheim O, Akbari M, Otterlei M, Nilsen H, Skorpen F, Aas PA, Hagen L, Krokan HE, Slupphaug G (2002) hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J Biol Chem 277(42):39926–39936CrossRefGoogle Scholar
  11. Kay L, Clore G, Bax A, Gronenborn A (1990) Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1 beta in solution. Science 249(4967):411–414ADSCrossRefGoogle Scholar
  12. Kim YJ, Wilson DM 3rd (2012) Overview of base excision repair biochemistry. Curr Mol Pharmacol 5(1):3–13CrossRefGoogle Scholar
  13. Kogan M, Rappaport J (2011) HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8:1–25CrossRefGoogle Scholar
  14. Krokan HE, Drabløs F, Slupphaug G (2002) Uracil in DNA: occurrence, consequences and repair. Oncogene 21:8935–8948CrossRefGoogle Scholar
  15. Langevin C, Maidou-Peindara P, Aas PA, Jacquot G, Otterlei M, Slupphaug G, Benichou S (2009) Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect. J Virol 83:10256–10263CrossRefGoogle Scholar
  16. Mansky LM, Preveral S, Selig L, Benarous R, Benichou S (2000) The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J Virol 74:7039–7047CrossRefGoogle Scholar
  17. Morellet N, Bouaziz S, Petitjean P, Roques BP (2003) Nmr structure of The HIV-1 regulatory protein Vpr. J Mol Biol 327(1):215–227CrossRefGoogle Scholar
  18. Mühle M, Lehmann M, Hoffmann K, Stern D, Kroniger T, Luttmann W, Denner J (2017) Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1. PLoS ONE 12(3):e0173454CrossRefGoogle Scholar
  19. Selig L, Benichou S, Rogel ME, Wu LI, Vodicka MA, Sire J, Benarous R, Emerman M (1997) Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J Virol 71:4842–4846Google Scholar
  20. Wen X, Casey Klockow L, Netkorchuk M, Sharifi HJ, de Noronha CMC (2012) The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover. Plos ONE 7:1 e30939ADSCrossRefGoogle Scholar
  21. Yan N, Cherepanov P, Daigle JE, Engelman A, Lieberman J (2009) The SET complex acts as a barrier to autointegration of HIV-1. PLoS Pathog 5:1–13CrossRefGoogle Scholar
  22. Yan N, O’Day E, Wheeler LA, Engelman A, Lieberman J (2011) HIV DNA is heavily uracilated, which protects it from autointegration. Proc Natl Acad Sci USA 108:9244–9249ADSCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Sorbonne Paris Cité, Laboratoire de Cristallographie et RMN BiologiquesUniversité Paris DescartesParisFrance

Personalised recommendations